Deep brain stimulation of the ventral hippocampus restores deficits in processing of auditory evoked potentials in a rodent developmental disruption model of schizophrenia

Schizophrenia Research

Volumn 143, Issue 2-3, 2013, Pages 377-383

  Ewing, Samuel G ^a   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Auditory evoked potential; Deep brain stimulation; Local field potential; MAM; Schizophrenia; Ventral hippocampus

Indexed keywords

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY DISCRIMINATION; BIPOLAR STIMULATING ELECTRODE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ELECTRIC POTENTIAL; ELECTRODE; ELECTRODE IMPLANT; ELECTROSTIMULATION; EVOKED AUDITORY RESPONSE; FEMALE; HIPPOCAMPUS; LIMBIC CORTEX; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY GATING; STEADY STATE; THALAMUS DORSOMEDIAL NUCLEUS; TREATMENT OUTCOME; VENTRAL TEGMENTUM;

ANIMALS; DEEP BRAIN STIMULATION; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY; FEMALE; HIPPOCAMPUS; MALE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 84872406876     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.11.023     Document Type: Article

References (46)

1. Adler L.E., Rose G., Freedman R. Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol. Biol. Psychiatry 1986, 21:787-798.
2. Benes F.M., Lim B., Matzilevich D., Walsh J.P., Subburaju S., Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(24):10164-10169.
3. Benes F.M., Lim B., Matzilevich D., Subburaju S., Walsh J.P. Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(52):20935-20940.
4. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 2012, 29(4):1165-1188.
5. Bickford-Wimer P.C., Nagamoto H., Johnson R., Adler L.E., Egan M., Rose G.M., Freedman R. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol. Psychiatry 1990, 27(2):183-192.
6. Boon P., Vonck K., De Herdt V., Van Dycke A., Goethals M., Goossens L., Van Zandijcke M., De Smedt T., Dewaele I., Achten R., Wadman W., Dewaele F., Caemaert J., Van Roost D. Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia 2007, 48(8):1551-1560.
7. Boutros N., Zouridakis G., Rustin T., Peabody C. The P50 component of the auditory evoked potential and subtypes of schizophrenia. Psychiatry Res. 1993, 47:243-254.
8. Brockhaus-Dumke A., Mueller R., Faigle U., Klosterkoetter J. Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia. Schizophr. Res. 2008, 99(1-3):238-249.
9. Buchsbaum M.S. The middle evoked response components and schizophrenia. Schizophr. Bull. 1977, 3(1):93-104.
10. Byne W., Buchsbaum M.S., Mattiace L.A., Hazlett E.A., Kemether E., Elhakem S.L., Purohit D.P., Haroutunian V., Jones L. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am. J. Psychiatry 2002, 159(1):59-65.
11. Canteras N.S., Swanson L.W. Projections of the ventral subiculum to the amygdala, septum, and hypothalamus: a PHAL anterograde tract-tracing study in the rat. J. Comp. Neurol. 1992, 324(2):180-194.
12. Clementz B., Blumenfeld L. Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia. Exp. Brain Res. 2001, 139(4):377-390.
13. Csernansky J.G., Wang L., Jones D., Rastogi-Cruz D., Posener J.A., Heydebrand G., Miller J.P., Miller M.I. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. Am. J. Psychiatry 2002, 159(12):2000-2006.
14. Danos P., Baumann B., Kra A., Stauch R., Krell D., Falkai P., Bogerts B. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr. Res. 2003, 60:141-155.
15. Dickerson D.D., Wolff A.R., Bilkey D.K. Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia. J. Neurosci. 2010, 30(37):12424-12431.
16. Erez Y., Tischler H., Moran A., Bar-Gad I. Generalized framework for stimulus artifact removal. J. Neurosci. Methods 2010, 191(1):45-59.
17. Ewing S., Grace A. Long-term high frequency deep brain stimulation of the nucleus accumbens drives time-dependent changes in functional connectivity in the rodent limbic system. Brain. Stimul. 2012, 10.1016/j.brs.2012.07.007.
18. Ford J., White P., Lim K. Schizophrenics have fewer and smaller P300s: a single-trial analysis. Biol. Psychiatry 1994, 35(2):96-103.
19. Freedman R., Waldo M., Bickford-Wimer P., Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schizophr. Res. 1991, 4(2):233-243.
20. Gilbert A.R., Rosenberg D.R., Harenski K., Spencer S., Sweeney J.A., Keshavan M.S. Thalamic volumes in patients with first-episode schizophrenia. Am. J. Psychiatry 2001, 158(4):618-624.
21. Grace A.A. Ventral hippocampus, interneurons, and schizophrenia: a new understanding of the pathophysiology of schizophrenia and its implications for treatment and prevention. Curr. Dir. Psychol. Sci. 2010, 19(4):232-237.
22. Grace A.A. Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology 2012, 62(3):1342-1348.
23. Groenwegen H.J., Vermeulen-van der Zee E., Kortschot T.E., Witter M.P. Organisation of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseoulus vulgaris leucogglutinin. Neuroscience 1987, 23(I):103-120.
24. Hazlett E.A., Buchsbaum M.S., Kemether E., Bloom R., Platholi J., Brickman A.M., Shihabuddin L., Tang C., Byne W. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Am. J. Psychiatry 2004, 161(2):305-314.
25. Hoover W.B., Vertes R.P. Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct. Funct. Sep. 2007, 212(2):149-179.
26. Hradetzky E., Sanderson T.M., Tsang T.M., Sherwood J.L., Fitzjohn S.M., Lakics V., Malik N., Schoeffmann S., O'Neill M.J., Cheng T.M., Harris L.W., Rahmoune H., Guest P.C., Sher E., Collingridge G.L., Holmes E., Tricklebank M.D., Bahn S. The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus. Neuropsychopharmacology 2012, 37:364-377.
27. Jerger K., Biggins C., Fein G. P50 suppression is not affected by attentional manipulations. Biol. Psychiatry 1992, 31(4):365-377.
28. Kapur S., Zipursky R., Jones C., Remington G., Houle S. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am. J. Psychiatry 2000, 157(4):514-520.
29. Kemether E., Buchsbaum M., Byne W., Hazlett E., Haznedar M., Brickman A., Platholi J., Bloom R. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch. Gen. Psychiatry 2003, 60(10):983.
30. Lavin A., Moore H.M., Grace A.A. Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopamine in adult rats. Neuropsychopharmacology 2005, 30(8):1426-1435.
31. Lewis D.A. Is there a neuropathology of schizophrenia? Recent findings converge on altered thalamic-prefrontal cortical connectivity. Neuroscientist 2000, 6(3):208-218.
32. Leyland C.M., Gwyther R.J., Ryiands J.M. An improved method for detecting drug effects in the open field. Psychopharmacology 1979, 63(1):33-37.
33. Lieberman J., Stroup T. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005, 353(12):1209-1223.
34. Lodge D.J., Grace A.A. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J. Neurosci. 2007, 27(42):11424-11430.
35. Lodge D.J., Grace A.A. Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia. Behav. Brain Res. 2009, 204(2):306-312.
36. Lodge D.J., Behrens M.M., Grace A.A. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J. Neurosci. 2009, 29(8):2344-2354.
37. Malaspina D., Storer S., Furman V., Esser P., Printz D., Berman A., Lignelli A., Gorman J., Van Heertum R. SPECT study of visual fixation in schizophrenia and comparison subjects. Biol. Psychiatry 1999, 46(1):89-93.
38. McCracken C.B., Grace A.A. Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. J. Neurosci. 2009, 29(16):5354-5363.
39. Mears R.P., Boutros N.N., Cromwell H.C. Reduction of prelimbic inhibitory gating of auditory evoked potentials after fear conditioning. Behav. Neurosci. 2009, 123(2):315-327.
40. Mikell C.B., McKhann G.M., Segal S., McGovern R.A., Wallenstein M.B., Moore H. The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia. Stereotact. Funct. Neurosurg. 2009, 87(4):256-265.
41. Moore H., Jentsch J.D., Ghajarnia M., Geyer M.A., Grace A.A. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol. Psychiatry 2006, 60(3):253-264.
42. Moxon K.A., Gerhardt G.A., Adler L.E. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia. Biol. Cybern. 2003, 88(4):265-275.
43. Penschuck S., Flagstad P., Didriksen M., Leist M., Michael-Titus A.T. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Eur. J. Neurosci. 2006, 23(1):279-284.
44. Popken G.J., Bunney W.E., Potkin S.G., Jones E.G. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(16):9276-9280.
45. Shimizu M., Fujiwara H., Hirao K., Namiki C., Fukuyama H., Hayashi T., Murai T. Structural abnormalities of the adhesio interthalamica and mediodorsal nuclei of the thalamus in schizophrenia. Schizophr. Res. 2008, 101(1-3):331-338.
46. Young K.A., Manaye K.F., Liang C., Hicks P.B., German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry 2000, 47(11):944-953.